Meet the VC: Accuitive Medical Ventures

OCTANe's Meet the VC series brings entrepreneurs and VCs together.

Join us as we meet Gerard van Hamel Platerink from Accuitive Medical Ventures. Gerard will tell us about his firm, his experience in the medical device and technology space, and their investment strategy.

Gerard van Hamel Platerink
Managing Director

Gerard helped to co-found AMV in 2003.  Prior to joining AMV, Gerard worked at Novoste Corporation, the cardiovascular brachytherapy company, in business development and corporate communications. Before joining Novoste, Gerard was in the Healthcare Group of Salomon Brothers (now Citigroup) in London, where he focused on investments and transactions in the medical device sector.

Gerard began his career with Kleinwort Benson, where he was an investment banker and member of the bank's private equity and mezzanine finance group. Gerard is a Dutch national, was born in Borneo in Southeast Asia, grew up in Africa and was educated in the UK where he got his BS in Physics from St. Andrews University and an MBA from Cambridge University.

Gerard is a co-founder of Halscion and currently has board responsibilities for Halscion, Axogen, Neuronetics, NeoVista, WaveTec and AqueSys.

About Accuitive Medical Ventures:

Accuitive Medical Ventures is a venture capital firm with committed capital of $230 million. We have offices in Palo Alto, CA, Atlanta, GA, Rochester, MN and Fernandina Beach, FL. We are a market driven firm looking for revolutionary, early stage medical device and technology investment opportunities.

Accuitive specializes in two distinct types of investments:

• venture financing for companies with outstanding technology and teams
• venture financing and management of technologies being developed within The Innovation Factory

In conjunction with The Innovation Factory, the Atlanta based medical device incubator, Accuitive has the resources and experience to create long-term value for medical technology inventors and innovators. The Innovation Factory is a successful medical technology incubator, having started ten medical technology companies over ten years, where Accuitive works to create new businesses from unique ideas and inventions.

Accuitive has established relationships with some of the industry’s leading institutions to offer emerging companies and investors the opportunity to build unique new businesses and long-term shareholder value. Accuitive’s connections to some of the industry’s leading practitioners and thought leaders enable us to add substantial value as investors and board members.